Bacterial Uropathogens and Antibiotic Susceptibility Patterns in Urinary Tract Infections: Cross-sectional Study at a Secondary Hospital in Southeast Bali
DOI:
https://doi.org/10.55927/eajmr.v3i5.9250Keywords:
Antibiotic, Resistance, Susceptibility, Uropathogens, UTIAbstract
Urinary tract infections (UTIs) are the most common infection in outpatient settings. Although antibiotics are the primary UTIs treatment, the antibiotic resistance threatens its effectiveness, posing a significant risk to public health. This study aims to explore the common bacterial uropathogens in UTIs patients and to plot the antibiotic susceptibility patterns through a cross-sectional retrospective study. Patients provided aseptic urine samples after consenting, which included clean-catch midstream urine and specimens obtained via straight or indwelling catheters, all stored in sterile containers. Escherichia coli was the most prevalent UTI-causing bacteria (29.2%), followed by Klebsiella pneumoniae (20.8%) and Pseudomonas aeruginosa (10%). Among all pathogens, 34.6% were Extended Spectrum β-lactamase (ESBL), including some of Escherichia coli and Klebsiella Pneumoniae. Escherichia coli was the most prevalent UTI-causing bacteria (29.2%), followed by Klebsiella pneumoniae (20.8%) and Pseudomonas aeruginosa (10%).
References
Alkhawaldeh, R., Farha, R. A., Hammour, K. A., & Alefishat, E. (2022). The Appropriateness of Empiric Treatment of Urinary Tract Infections in a Tertiary Teaching Hospital in Joran: A Cross-Sectional Study. Antibiotics, 11(5). https://doi.org/10.3390/antibiotics11050629
Al-Shahrani, G. S., & Belali, T. M. (2024). Frequency of drug resistant bacterial isolates among pregnant women with UTI in maternity and children’s hospital , Bisha , Saudi Arabia. Scientific Reports, 1–8. https://doi.org/10.1038/s41598-024-58275-5
Altamimi, I., Almazyed, A., Alshammary, S., Altamimi, A., Alhumimidi, A., Alnutaifi, R., Malhis, M., & Altamimi, A. (2023). Bacterial Pathogens and Antimicrobial Susceptibility Patterns of Urinary Tract Infections in Children during COVID-19 2019–2020: A Large Tertiary Care Center in Saudi Arabia. Children, 10(6), 1–10. https://doi.org/10.3390/children10060971
Ariana, N., Pestariati, P., Sasongkowati, R., & Kusumaningrum, D. (2020). RESISTANCE PATTERN OF Escherichia coli AGAINTS ANTIBIOTICS IN URINARY TRACT INFECTION PATIENTS IN RSUD DR. SOETOMO SURABAYA. Journal of Community Medicine and Public Health Research, 1(2), 53. https://doi.org/10.20473/jcmphr.v1i2.21693
Bonkat, G., Bartoletti, R., Bruyère, F., Cai, T., Geerlings, S. E., Köves, B., Kranz, J., Schubert, S., Pilatz, A., Veeratterapillay, R., Wagenlehner, F., Bausch, G. A. K., Devlies, W., & Smith, G. O. E. J. (2023). EAU Guidelines on Urological Infections.
Carlotta, N., Nitin, M., Dave, B., & Bhaskar Kumar, S. (2024). Gram negative bacteria related urinary tract infections: spectrum of antimicrobial resistance over 9 years in a University tertiary referral Hospital. Therapeutic Advances in Infectious Disease, 11, 1–10. https://doi.org/10.1177/20499361241228342
Cho, S. Y., Choi, S. M., Park, S. H., Lee, D. G., Choi, J. H., & Yoo, J. H. (2016). Amikacin therapy for urinary tract infections caused by extended-spectrum β-lactamase- producing Escherichia coli. Korean Journal of Internal Medicine, 31(1), 156–161. https://doi.org/10.3904/kjim.2016.31.1.156
Critchley, I. A., Nicole Cotroneo, Pucci, M. J., & Rodrigo Mendes. (2019). The burden of antimicrobial resistance among urinary tract isolates of Escherichia coli in the United States in 2017. PLoS ONE, 14(12), 1–11. https://doi.org/10.1371/journal.pone.0220265
Dasgupta-Tsinikas, S., Zangwill, K. M., Nielsen, K., Lee, R., Friedlander, S., Donovan, S. M., Van, T. T., Butler-Wu, S. M., Batra, J. S., Yeh, S. H., Tarro, T., Cielo, M., Navarro, A., Caldera, J. R., Pham, T., White, K. S., Regalado, M., Sasu, A., Bolaris, M., … Miller, L. (2022). Treatment and Epidemiology of Third-Generation Cephalosporin-Resistant Urinary Tract Infections. Pediatrics, 150(1), 1–19. https://doi.org/10.1542/peds.2021-051468
de Cueto, M., Aliaga, L., Alós, J. I., Canut, A., Los-Arcos, I., Martínez, J. A., Mensa, J., Pintado, V., Rodriguez-Pardo, D., Yuste, J. R., & Pigrau, C. (2017). Executive summary of the diagnosis and treatment of urinary tract infection: Guidelines of the Spanish Society of Clinical Microbiology and Infectious Diseases (SEIMC). Enfermedades infecciosas y microbiologia clinica, 35(5), 314–320. https://doi.org/10.1016/j.eimc.2016.11.005
Faine, B. A., Rech, M. A., Vakkalanka, P., Gross, A., Brown, C., Harding, S. J., Slocum, G., Zimmerman, D., Zepeski, A., Rewitzer, S., Howington, G. T., Campbell, M., Dawson, J., Treu, C. N., Nelson, L., Jones, M., Flack, T., Porter, B., Sarangarm, P., … Talan, D. A.
(2022). High prevalence of fluoroquinolone-resistant UTI among US emergency department patients diagnosed with urinary tract infection, 2018–2020. Academic Emergency Medicine, February, 1096–1105. https://doi.org/10.1111/acem.14545
Gebretensaie, Y., Atnafu, A., Girma, S., Alemu, Y., & Desta, K. (2023). Prevalence of Bacterial Urinary Tract Infection, Associated Risk Factors, and Antimicrobial Resistance Pattern in Addis Ababa, Ethiopia: A Cross-Sectional Study. Infection and Drug Resistance, 16(May), 3041–3050. https://doi.org/10.2147/IDR.S402279
Hariati, H., Suza, D. E., & Tarigan, R. (2019). Risk factors analysis for catheter-associated urinary tract infection in medan, Indonesia. Open Access Macedonian Journal of Medical Sciences, 7(19), 3189–3194. https://doi.org/10.3889/oamjms.2019.798
Kang, C. I., Kim, J., Park, D. W., Kim, B. N., Ha, U. S., Lee, S. J., Yeo, J. K., Min, S. K., Lee, H., & Wie, S. H. (2018). Clinical practice guidelines for the antibiotic treatment of community-acquired urinary tract infections. Infection and Chemotherapy, 50(1), 67–100. https://doi.org/10.3947/ic.2018.50.1.67
Kang, K. T., Ng, K., Kendrick, J., Tilley, P., Ting, J., Rassekh, S., Murthy, S., & Roberts, A. (2020). Third-generation cephalosporin-resistant urinary tract infections in children presenting to the paediatric emergency department. Paediatrics and Child Health (Canada), 25(3), 166–172. https://doi.org/10.1093/pch/pxy175
Kunz Coyne, A. J., El Ghali, A., Holger, D., Rebold, N., & Rybak, M. J. (2022). Therapeutic Strategies for Emerging Multidrug-Resistant Pseudomonas aeruginosa. Infectious Diseases and Therapy, 11(2), 661–682. https://doi.org/10.1007/s40121-022-00591-2
Mareș, C., Petca, R.-C., Popescu, R.-I., Petca, A., Mulțescu, R., Bulai, C. A., Ene, C. V., Geavlete, P. A., Geavlete, B. F., & Jinga, V. (2024). Update on Urinary Tract Infection Antibiotic Resistance—A Retrospective Study in Females in Conjunction with Clinical Data. Life, 14(1), 106. https://doi.org/10.3390/life14010106
Mark, D. G., Hung, Y. Y., Salim, Z., Tarlton, N. J., Torres, E., & Frazee, B. W. (2021). Third-Generation Cephalosporin Resistance and Associated Discordant Antibiotic Treatment in Emergency Department Febrile Urinary Tract Infections. Annals of Emergency Medicine, 78(3), 357–369. https://doi.org/10.1016/j.annemergmed.2021.01.003
Masajtis-Zagajewska, A., & Nowicki, M. (2017). New markers of urinary tract infection. Clinica Chimica Acta, 471(February), 286–291. https://doi.org/10.1016/j.cca.2017.06.003
McCann, E., Sung, A. H., Ye, G., Vankeepuram, L., & Tabak, Y. P. (2020). Contributing factors to the clinical and economic burden of patients with laboratory-confirmed carbapenem-nonsusceptible gram-negative urinary tract infections. ClinicoEconomics and Outcomes Research, 12, 191–200. https://doi.org/10.2147/CEOR.S234840
Montelin, H., Camporeale, A., Hallgren, A., Angelin, M., Hogvall, J., Balkhed, Å. Ö., Vading, M., Giske, C. G., & Tängdén, T. (2024). Treatment, outcomes and characterization of pathogens in urinary tract infections caused by ESBL-producing Enterobacterales: a prospective multicentre study. Journal of Antimicrobial Chemotherapy, 79(3), 531–538. https://doi.org/10.1093/jac/dkad402
Naushad, V. A., Purayil, N. K., Wilson, G. J., Chandra, P., Joseph, P., Khalil, Z., Zahid, M., Kayakkool, M. K., Shaik, N. J., Ayari, B., Chalihadan, S., Elmagboul, E. B. I., & Doiphode, S. H. (2022). Epidemiology of urinary tract infection in adults caused by extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae – a case–control study from Qatar. IJID Regions, 3(January), 278–286. https://doi.org/10.1016/j.ijregi.2022.05.001
Öztürk, R., & Murt, A. (2020). Epidemiology of urological infections: a global burden. World Journal of Urology, 38(11), 2669–2679. https://doi.org/10.1007/s00345-019-03071-4
Pantha, S., Parajuli, H., Arjyal, C., Karki, S. T., & Shrestha, D. (2024). Phenotypic characterization of ESBL-producing urinary isolates of E. coli and Klebsiella spp. in a tertiary care children’s hospital in Nepal. Tropical Medicine and Health, 52(1). https://doi.org/10.1186/s41182-024-00587-3
Perdana, M. A., Wahyuni, D. D., & Yunita, R. (2023). Characteristics and susceptibility pattern of catheter-associated urinary tract infections (CAUTI) bacteria in Indonesia: A study in a national reference hospital of Sumatra region 2020-2021. Narra J, 3(3), e436. https://doi.org/10.52225/narra.v3i3.436
Raz, R., Chazan, B., Kennes, Y., Colodner, R., Rottensterich, E., Dan, M., Lavi, I., Stamm, W., Rohana, Y., Fainlaid, N., Bennet, L., Cantarell, M., & Gvidolin, A. (2002). Empiric use of trimethoprim-sulfamethoxazole (TMP-SMX) in the treatment of women with uncomplicated urinary tract infections, in a geographical area with a high prevalence of TMP-SMX-resistant uropathogens. Clinical Infectious Diseases, 34(9), 1165–1169. https://doi.org/10.1086/339812
Reda, B. K., Molla, G., Gedefie, A., Gebretsadik, D., Tilahun, M., Belete, M. A., & Shibabaw, A. (2023). Antibiogram of uropathogens and associated risk factors among asymptomatic female college students in Dessie town, Northeast Ethiopia. PLoS ONE, 18(11 November), 1–18. https://doi.org/10.1371/journal.pone.0276033
Shields, R. K., Zhou, Y., Kanakamedala, H., & Cai, B. (2021). Burden of illness in US hospitals due to carbapenem-resistant Gram-negative urinary tract infections in patients with or without bacteraemia. BMC Infectious Diseases, 21(1), 1–12. https://doi.org/10.1186/s12879-021-06229-x
Shkalim Zemer, V., Ashkenazi, S., Levinsky, Y., Richenberg, Y., Jacobson, E., Nathanson, S., Shochat, T., Kushnir, S., Cohen, M., & Cohen, A. H. (2024). Pathogens Causing Pediatric Community Acquired Urinary Tract Infections and Their Increasing Antimicrobial Resistance: A Nationwide Study. Pathogens, 13(3), 201. https://doi.org/10.3390/pathogens13030201
Stapleton, A. E., Wagenlehner, F. M. E., Mulgirigama, A., & Twynholm, M. (2020). Escherichia coli resistance to fluoroquinolones in community-acquired uncomplicated urinary tract infection in women: a systematic review. Antimicrobial Agents and Chemotherapy, 64(10), 1–44. https://doi.org/10.1128/AAC.00862-20
Tarek, A., Abdalla, S., Dokmak, N. A., Ahmed, A. A., El-Mahdy, T. S., & Safwat, N. A. (2024). Bacterial Diversity and Antibiotic Resistance Patterns of Community-Acquired Urinary Tract Infections in Mega Size Clinical Samples of Egyptian Patients: A Cross-Sectional Study. Cureus, 16(1), 1–11. https://doi.org/10.7759/cureus.51838
Thompson, D., Xu, J., Ischia, J., & Bolton, D. (2024). Fluoroquinolone resistance in urinary tract infections: Epidemiology, mechanisms of action and management strategies. BJUI Compass, 5(1), 5–11. https://doi.org/10.1002/bco2.286
Wagenlehner, F., Tandogdu, Z., Bartoletti, R., Cai, T., Cek, M., Kulchavenya, E., Köves, B., Naber, K., Perepanova, T., Tenke, P., Wullt, B., Bogenhard, F., & Johansen, T. E. B. (2016). The global prevalence of infections in urology study: A long-term,worldwide surveillance study on urological infections. Pathogens, 5(1), 1–8. https://doi.org/10.3390/pathogens5010010
WHO. Antimicrobial Resistance: Global Report on Surveillance. 2014. https://www.who.int/publications/i/item/9789241564748
Yang, X., Chen, H., Zheng, Y., Qu, S., Wang, H., & Yi, F. (2022). Disease burden and long-term trends of urinary tract infections: A worldwide report. Frontiers in Public Health, 10. https://doi.org/10.3389/fpubh.2022.888205
Zhou, Y., Zhou, Z., Zheng, L., Gong, Z., Li, Y., Jin, Y., Huang, Y., & Chi, M. (2023). Urinary Tract Infections Caused by Uropathogenic Escherichia coli: Mechanisms of Infection and Treatment Options. International Journal of Molecular Sciences, 24(13). https://doi.org/10.3390/ijms241310537
Zhu, C., Wang, D. Q., Zi, H., Huang, Q., Gu, J. M., Li, L. Y., Guo, X. P., Li, F., Fang, C., Li, X. D., & Zeng, X. T. (2021). Epidemiological trends of urinary tract infections, urolithiasis and benign prostatic hyperplasia in 203 countries and territories from 1990 to 2019. Military Medical Research, 8(1), 1–12. https://doi.org/10.1186/s40779-021-00359-8
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 I Gede Yogi Prema Ananda, I Kadek Bayu Adhy Candra, Herman Yudawan, I Gusti Lanang Andi Suharibawa, Radika Naufal Hadi Surya
This work is licensed under a Creative Commons Attribution 4.0 International License.
